Stick, S. M., Foti, A., Ware, R. S., Tiddens, H. A. W. M., Clements, B. S., Armstrong, D. S., Selvadurai, H., Tai, A., Cooper, P. J., Byrnes, C. A., Belessis, Y., Wainwright, C., Jaffe, A., Robinson, P., Saiman, L., & Sly, P. D. (2022). The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial. The Lancet Respiratory Medicine, 10(8), 776–784. https://doi.org/10.1016/s2213-2600(22)00165-5
Subjects:
Bronchiectasis
(MeSH)
Cystic Fibrosis
(MeSH)
Publication Type:
Article
Unique ID:
10.1016/S2213-2600(22)00165-5
PMID:
Journal:
Publication Date:
Data Source:
Scopus